Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00206739
Status:
COMPLETED
Last Update Posted:
2010-03-30
First Post:
2005-09-13
Brief Title:
Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infants
Sponsor:
Bernhard Nocht Institute for Tropical Medicine
Organization:
Bernhard Nocht Institute for Tropical Medicine
Study Overview
Official Title:
Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infant a Randomized Double-blind and Placebo-controlled Clinical Trial
Status:
COMPLETED
Status Verified Date:
2005-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the effectiveness of Intermittent Preventive Treatment in Infants IPTi with Sulfadoxine-Pyrimethamine to reduce the numbers of malaria attacks episodes of anemia and the overall morbidity and mortality
Detailed Description:
In order to define the effectiveness of Intermittent Preventive Treatment in Infants IPTi with Sulfadoxine-Pyrimethamine a novel principle of malaria intervention the following parameters are evaluated i the level of protection from malaria attacks and episodes of anemia during the treatment period ii the level of protection from severe malaria during the treatment period iii the effect on malaria morbidity after sustaining treatment iv the decrease of overall morbidity and mortality including the number of hospital admissions and visits of hospital outpatient departments v the influence of the intervention on the development of drug resistances vi the impact of the intervention on the development of immunity vii the possible influence of the intervention on sub-clinical organ dysfunction due to chronic Plasmodium falciparum infection Parts of the study are performed in collaboration with the Laboratory of Research Hospital Albert Schweitzer Lambaréné Gabon and the School of Medicine and Health Sciences University of Development Studies Tamale Ghana
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 01KA0202 | None | None | None |